Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company ▴	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
FBLG	FibroBiologics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$18.65M	n/a	-302.9%	n/a	-$0.42
FHTX	Foghorn Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$30.91M	-$74.28M	-240.3%	n/a	36.8%	-$1.18
FBIO	Fortress Biotech, Inc. Manufacturing · Year ended 2025-12-31 · USD	$63.26M	$6.82M	10.8%	13.7%	9.7%	-$0.07
FULC	Fulcrum Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$74.88M	n/a	-21.5%	-100.0%	-$1.18
GALT	Galectin Therapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$30.84M	n/a	n/a	n/a	-$0.48
GNLX	Genelux Corp Manufacturing · Year ended 2025-12-31 · USD	$8.0K	-$32.15M	n/m	-278.5%	0.0%	-$0.86
GERN	Geron Corp Manufacturing · Year ended 2025-12-31 · USD	n/a	-$83.50M	n/a	-37.0%	n/a	-$0.13
GRI	GRI Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$11.96M	n/a	-199.0%	n/a	-$121.80
GTBP	GT Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$28.35M	n/a	-490.0%	n/a	-$6.68
GYRE	Gyre Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$116.59M	$9.88M	8.5%	9.3%	10.2%	$0.02
GANX	Gain Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$20.16M	n/a	-108.6%	n/a	-$0.61
EOCN	Galmed Pharmaceuticals Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	$6.90M	n/a	43.7%	n/a	$2.39
GNPX	Genprex, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$16.23M	n/a	-203.8%	n/a	n/a
GOVX	GeoVax Labs, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.49M	-$21.46M	-862.3%	-561.2%	-37.1%	n/a
GOSS	Gossamer Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$48.47M	-$170.37M	-351.5%	n/a	-57.7%	-$0.75
GRCE	Grace Therapeutics, Inc. Manufacturing · Year ended 2026-03-31 · USD	n/a	-$7.79M	n/a	-12.2%	n/a	-$0.47
GLSI	Greenwich LifeSciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$19.36M	n/a	n/m	n/a	-$1.43
HROW	Harrow, Inc. Manufacturing · Year ended 2025-12-31 · USD	$272.30M	-$5.14M	-1.9%	-9.8%	36.4%	-$0.14
HCWB	HCW Biologics Inc. Manufacturing · Year ended 2025-12-31 · USD	$54.2K	-$7.96M	n/m	-287.9%	-97.9%	-$10.63
HRTX	Heron Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$154.90M	-$20.20M	-13.0%	-140.9%	7.4%	-$0.12
HCM	HUTCHMED (China) Ltd Manufacturing · Year ended 2025-12-31 · USD	$548.51M	$456.91M	83.3%	36.5%	-13.0%	$0.52
HYPD	Hyperion Defi, Inc. Manufacturing · Year ended 2025-12-31 · USD	$813.5K	-$45.31M	n/m	-110.4%	n/m	-$9.40
HRMY	Harmony Biosciences Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$868.45M	$158.69M	18.3%	18.2%	21.5%	$2.71
HEPA	Hepion Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$8.28M	n/a	-310.3%	n/a	-$0.88
IDYA	IDEAYA Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$218.71M	-$113.70M	-52.0%	-11.1%	n/m	-$1.28

Rows per page: 2550 100